The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies [Corrigendum]

Donohue JF, Ozol-Godfrey A, Goodin T, Sanjar S. Int J Chron Obstruct Pulmon Dis. 2020;15:745–754. The authors have advised there is an error in Figure 4 on page 751. The Q2 subgroup of the placebo arm has the label of “−0.012” which should read “0.012”. The authors apologize for this error. Read the original article